| Literature DB >> 19144517 |
Antonello Mai1, Dante Rotili, Domenico Tarantino, Angela Nebbioso, Sabrina Castellano, Gianluca Sbardella, Marc Tini, Lucia Altucci.
Abstract
We identified a series of 4-hydroxyquinolines bearing a C1 to C15 alkyl chain at the C2 position and a carbethoxy/carboxy group at the C3 position of the quinoline nucleus (MC compounds), endowed with selective inhibitory activity against the p300/CBP HAT enzymes. Enzyme inhibition was investigated using in vitro HAT assays and by western blot analysis of cellular lysates to examine the acetylation levels of histone H3 and alpha-tubulin. When tested in U937 cells, some compounds displayed pro-apoptotic or cytodifferentiating properties.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19144517 DOI: 10.1016/j.bmcl.2008.12.097
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823